MedPath

LACIDIPINO TEVA 4 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

LACIDIPINO TEVA 4 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Commercialized
Register Number

73875

Prescription Type

Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración

Authorization Date

Apr 12, 2011

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number73875
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

LACIDIPINOActive
Quantity: 4,0 mg
Name: LACIDIPINO

ATC CLASSIFICATION (3)

C08C
C08CA
C08CA09

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.